Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Active not recruiting 2Recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Breast Neoplasms 41Ovarian Neoplasms 4Neoplasms 4Neoplasm Metastasis 4Squamous Cell Carcinoma of Head and Neck 3Lymphoma 3Breast Diseases 3Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neuroblastoma 2Neoplasms by Site 2Medulloblastoma 2Lymphoma, Mantle-Cell 2Liposarcoma 2Hematologic Neoplasms 2Glioma 2Carcinoma, Renal Cell 2Breast Neoplasm Female 2Xanthogranuloma, Juvenile 1Wilms Tumor 1Venous Thromboembolism 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Unilateral Breast Neoplasms 1Thyroid Neoplasms 1

Interventions

Radiotherapy 3Radiation 3palbociclib 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Doxorubicin 2zimberelimab 1talimogene laherparepvec 1sotigalimab 1ribociclib 1pazopanib 1eribulin 1enzalutamide 1durvalumab 1cemiplimab 1abemaciclib 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Nivolumab 1Midazolam 1Letrozole 1Ipilimumab 1Ifosfamide 1Fulvestrant 1Everolimus 1Disulfides 1CTLA-4 Antigen 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × Liposarcoma × palbociclib × Clear all
NCT05694871 2026-05-11

Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
77 enrolled
Sarcoma

Liposarcoma

NCT04438824 2025-10-14

Palbociclib and INCMGA00012 in People With Advanced Liposarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
42 enrolled
Sarcoma

Liposarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡